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Abstract 
Although the mechanism of folate intestinal transport has been the subject of intensive studies, very little is known about he molecular 
identity of the transport system(s) involved. In this investigation, we screened a mouse intestinal cDNA library using as probe the cDNA 
clone of a reduced folate carder (RFCI) of mouse leukemia LI210 cells, and identified a positive clone, IFCI(RFC1). The cloned cDNA 
consisted of 2274 base pairs with an open reading frame that encodes a putative polypeptide of 512 amino acids with a predicted 
molecular mass of 58112 daltons and 12 putative transmembrane domains. The polypeptide appears to carry a net positive charge 
(pl = 8.6) which may be important for its interaction with the negatively charged substrate. Functional identity of the IFCI(RFC1) clone 
was established by expression in Xenopus oocytes. An 1 l-fold increase in 5-methyltetrahydrofolate (5-MTHF) uptake was observed in 
oocytes injected with 10 ng IFCI(RFC1) cRNA compared to water-injected controls. The expressed folate uptake in the cRNA injected 
oocyte was: (1) 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS)-sensitive; and (2) saturable with an apparent K m of 1.99 + 0.32 
/xM, and a Vm~  of 3782 + 188 fmol/oocyte per h. The distribution of mRNA species complementary to IFCI(RFC1) in different mouse 
tissues was examined by Northern blot analysis. In addition to the small intestine, expression of such mRNA species were also found in 
the kidney, large intestine, brain, heart and liver. Furthermore, mRNA species complementary to IFCI(RFC1) were also detected by 
Northern blot analysis in the small intestine of human and other animal species (rat and rabbit). Expression of mRNA complementary to 
IFCI(RFC1) was markedly higher in rat intestinal villus cells than in crypt cells. These results represent the first identification of a folate 
transporter in mammalian i testine. 
Keywords: Intestinal folate transport; Folate transport; cDNA library; DNA sequencing; (Xenopus oocyte) 
1. Introduction 
The coenzyme derivatives of folic acid play a central 
role in one-carbon metabolism, and are necessary for the 
synthesis of purine and pyrimidine precursors of nucleic 
acids, for the metabolism of certain amino acids, and for 
the initiation of protein synthesis in mitochondria [1-4]. 
Folate deficiency is the most prevalent vitamin deficiency 
in the Western hemisphere, with a significant number of 
cases resulting from impairment of intestinal absorption of 
Abbreviations: DIDS, 4,4'-diisothiocyanatostilbene-2,2'-disulfonic 
acid; 5-MTHF, (6S)-5-methyltetrahydrofolic acid.
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the vitamin [5,6]. Malabsorption of folate is common in 
various diseases of the small intestine [5,7-9] and has been 
associated with the use of certain pharmacological gents 
(e.g., sulfasalazine, phenytoin) [9-12]. Malabsorption of 
folate is also caused by congenital defects in the intestinal 
absorption process of the vitamin [13-18]. Folate defi- 
ciency leads to a variety of clinical abnormalities including 
megaloblastic anemia, growth retardation and derangement 
of one-carbon metabolism [1,4,5]. 
Mammals cannot synthesize folate but instead must 
obtain it from exogenous sources through intestinal absorp- 
tion. Dietary folates exist mainly in polyglutamate forms 
which are enzymatically hydrolyzed by folate conjugase. 
The resulting monoglutamate forms are then absorbed by 
the enterocyte predominantly in the proximal small intes- 
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tine. The mechanism of folate absorption in the small 
intestine has been the subject of intense investigation, with 
specialized carrier-mediated transport systems having been 
identified at both the brush-border membrane (BBM) and 
the basolateral membrane (BLM) domains of the absorp- 
tive cells. Despite the large volume of published works on 
intestinal folate absorption (which is believed to exceed 
the number of published work on intestinal absorption of 
all other vitamins; Refs. [6,19]), nothing is known about 
the molecular identity of the intestinal folate transporter(s) 
and their cellular regulation. This information is necessary 
for a thorough understanding both of the folate absorption 
process under normal physiological conditions and of the 
causes of derangement that occur in the absorption process 
under certain pathophysiological onditions. 
In the present study, we used a cDNA probe (RFC1) of 
a recently cloned reduced folate carrier of mouse leukemia 
L1210 cells [20] to screen a mouse intestinal cDNA library 
and have identified and sequenced a positive clone, 
IFCI(RFC1), that may be involved in normal folate intesti- 
nal absorption. 
2. Materials and methods 
folate carrier). The remaining three had different inserts 
and were saved for future analysis. 
2.2. cDNA sequence determination and analysis 
The cDNA insert of plFC1 was sequenced on both 
strands in its entirety by Sanger's method of dideoxy chain 
termination [23] using the Sequenase kit version 2.0 (United 
States Biochemical, Cleveland, OH) following instructions 
provided by the manufacturer. The nucleotide sequence 
was analyzed using computer programs DNA Strider 1.2 
and MacPattem 3.2 with database Prosite release 12 [24,25] 
to obtain the deduced amino acid sequence of the major 
open reading from (ORF) and potential regulatory sites of 
the putative polypeptide. 
2.3. Preparation of IFCI(RFC1) cRNA 
cRNA was prepared from plFC1 linearized with XhoI 
by in vitro transcription using T3 mMessage mMachine 
(Ambion, Texas). The resulting cRNA was then phenol 
extracted, ethanol precipitated, resuspended in water and 
micro-injected into oocytes as described in Ref. [22]. 
[3',5,7,9-3H]-(6S)-5-Methyltetrahydrofolic acid (3H-5- 
MTHF) (i.e., the t-form; spec. act. 21.7 Ci/mmol; radio- 
chemical purity 98%) was the generous gift of Dr. Barton 
Kamen, Univ. Texas, Southwestern Medical Center. The 
intestinal epithelial cell line IEC-6 was obtained from 
American Tissue Type Culture (Rockville, MD). All other 
chemicals, reagents and kits were obtained from commer- 
cial sources. 
2.1. Cloning of an intestinal folate carrier 
A directional cDNA library was constructed using a 
modified lambda vector (ZAP Express, Stratagene, La 
Jolla, CA) and doubly selected poly(A) + RNA isolated by 
the method of Chirgwin et al. [21] from an adult female 
DBA2 mouse jejunum (Jackson Laboratories, Bar Harbor, 
ME) by cesium chloride density gradient centrifugation 
[22]. Three hundred thousand clones were screened at high 
stringency (0.2 × SSC, 0.1% SDS, 55°C) using randomly 
labeled BamHI-KpnI 2.3 kb fragment from plasmid pRFC 1 
[20]. After four rounds of plaque purification, twelve posi- 
tive clones were identified. Plasmids containing the corre- 
sponding cDNA were obtained by in vivo excision accord- 
ing to ZAP Express instructions. Nine of these contained 
overlapping inserts as determined by restriction mapping 
and terminal sequencing. Four of those nine contained 
identical 2.3 kb inserts which corresponded with the size 
of the hybridizing mRNA species of mouse small intestine 
on Northern blot (Fig. 4). One of the four plasmids was 
selected for further study and was named pIFCI (intestinal 
2.4. Expression studies in Xenopus oocytes 
Oocytes were obtained from healthy Xenopus laeL, is 
purchased from Xenopus I (Ann Arbor, MI). Stage V-VI 
oocytes were defolliculated and micro-injected with 50 nl 
in vitro transcribed cRNA (50 ng) or with water (control). 
Oocytes were incubated at 18°C for 3 to 8 days and 
assayed for folate uptake by incubating 5-8 oocytes in 200 
/zl of Ringer solution (in mM: 120 NaC1, 2 KC1, 1.8 
CaC12, and 20 Mes-Tris; pH 5.5-8) containing 0.25 /zM 
of labeled and different concentrations of unlabeled 5- 
MTHF and/or other compounds at room temperature. 
Incubation was terminated by the addition of 5 ml of 
ice-cold Ringer solution followed by four successive 
washes with the same buffer. Cells were then transferred 
individually to scintillation vials, dissolved in 250 /xl of 
10% sodium dodecyl sulfate; scintillation fluid was added 
and radioactivity was counted. 
As control for oocyte quality, 10 ng of in vitro tran- 
scribed SGLT-1 cRNA (the plasmid containing the intesti- 
nal sodium-dependent glucose transporter SGLT-1 cDNA 
was a generous gift from Dr. M.A. Hediger, Harvard 
Medical School, Boston, MA) was micro-injected into 
Xenopus oocytes, which were incubated for 5 days and 
assayed for methyl a-D-[U-14C]glucopyranoside (3.5 /zM) 
uptake. Generally, there was approximately a 65-fold in- 
crease in uptake activity over water-injected controls (2400 
+400 vs. 40+ 10 fmol/oocyte per h, respectively). 
Oocytes from donors demonstrating a good expression of 
SGLT-1 were used for studies of IFCI(RFCI) expression. 
The metabolic form(s) of the radioactivity taken up by 
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cRNA-injected oocytes following 1 h incubation with 3H- 
5-MTHF was determined by thin-layer chromatography 
[26]. After incubation, oocytes were washed, then homoge- 
nized in 70% ethanol containing 5% /3-mercaptoethanol. 
The supematant was then applied onto a non-ionic cellu- 
lose pre-coated thin-layer chromatography plate and chro- 
matographed with 0.1 M phosphate buffer, 5% /3-mer- 
captoethanol, pH 7.0. 
2.5. Northern analysis 
Total RNA and poly(A) + RNA were prepared from 
different mouse tissues and from the small intestine of 
human and different animal species as described [22]. 
Samples (5 /xg) of mRNA containing ethidium bromide 
were electrophoresed through RNA-denaturing els, capil- 
lary blotted onto Magna 0.22 /xm nylon membranes (Mi- 
cron Separations, Westport, MA) [27], and UV-cross- 
linked. Hybridization was done using randomly labeled 
EcoRI-XhoI 2.3 kb fragment from plasmid plFCI [20]. 
After washing at high stringency (0.2 × SSC, 0.1% SDS, 
55°C, 30 rain), the blots were autoradiographed for 1 to 10 
days at -80°C with intensifying screens. The hybridiza- 
tion signal was normalized to cyclophilin expression by 
scanning densitometry (LKB, Bromma, Switzerland). 
2.6. Cell culture and uptake studies 
The rat-derived intestinal epithelial cell line IEC-6 was 
used between passage 16 and 20. Cell culturing, mainte- 
nance and use in uptake studies were performed as de- 
scribed in Ref. [28]. Protein contents of cell digests were 
measured in parallel wells by the method of Lowry et al. 
[29]. Uptake data presented in this paper are means + S.E. 
of multiple separate monolayers performed on two sepa- 
rate occasions and are expressed in pmol/mg protein per 
unit time. 
2.7. Isolation of rat villus and crypt intestinal epithelial 
cells 
Villus and crypt intestinal cells were isolated as de- 
scribed in Ref. [30]. Fractions 1 and 6, containing mostly 
villus tip and crypt cells, respectively, were saved for 
further study. Na+-dependent D-glucose uptake and alka- 
line phosphatase activity were assayed as markers of villus 
cells. Na+-dependent D-glucose uptake was 23-fold higher 
in fraction 1 (villus cells) than in fraction 6 (crypt cells) 
(7.98 + 1.60 vs. 0.35 _+ 0.09 pmol/mg protein per 15 min, 
respectively). Also, alkaline phosphatase activity was en- 
riched 4.8-fold in fraction 1 over fraction 6 (0.451 _+ 0.05 
vs. 0.094 + 0.01 /zmol/mg protein per rain, respectively). 
These results are in good agreement with published find- 
ings [30,31]. Thymidine incorporation, an index of thymi- 
dine kinase activity, itself a marker of crypt cells, was also 
determined as described in Refs. [31-33]. Isolated cells 
were incubated in oxygenated buffer A containing 40 /xCi 
of [3H]thymidine (Amersham, Arlington Heights, IL) at 
37°C for 2 h and then centrifuged at 500 × g for 5 min. 
Pellets were washed twice with 0.9% NaC1, and the tri- 
chloroacetic acid (TCA)-precipitable radioactivity was de- 
termined as described. Thymidine kinase activity, was 
0.3 _+ 0.03 fmol/mg TCA-precipitable material per 2 h in 
fraction 1 (villus), and 2.0 + 0.18 fmol/mg TCA-precipi- 
table material per 2 h in fraction 6 (crypt), indicating a 
successful separation of villus from crypt cells. Poly(A) + 
RNA was isolated from the villus tip and crypt cells and 
used in Northern blot analysis to determine the relative 
distribution of mRNA complementary to IFCI(RFC1). 
3. Results 
3.1. Sequence analysis of IFCI(RFC1) 
The cDNA insert of plFC1 clone was sequenced on 
both strands in its entirety and found to consist of 2274 
nucleotide pairs, including a tail of 19 adenylate residues 
(GenBank accession no. L36539) (Fig. 1). The cDNA 
insert was divided into three regions: (1) nucleotides 1-96 
comprise the 5'-untranslated region (5'-UTR); (2) nu- 
cleotides 97-1635 comprise the major open reading frame 
(ORF); and (3) nucleotides 1636-2274 comprise the 3'-un- 
translated region (3'-UTR). The major ORF has an initia- 
tion site that surrounds the initiator methionine (5'-GGCAA 
CATGG-3') matching 8 out of 10 nucleotides of the Kozak 
consensus equence (5'-GCCRCCATGG-3'; R = purine) 
[34]. The ORF encoded a putative polypeptide of 512 
amino acids, with a predicted molecular mass of 58112 
daltons. Examination of the predicted amino acid sequence 
of the ORF revealed two potential N-glycosylation sites at 
Ash-211 and Asn-277; one cAMP- and/or cGMP-depen- 
dent protein kinase phosphorylation site at Thr-58; five 
protein kinase C phosphorylation sites at Ser-24, Thr-236, 
Thr-245, Ser-324 and Ser-412; three casein kinase II phos- 
phorylation sites at Thr-245, Ser-467 and Ser-477; four 
N-myristoylation sites at Gly-161, Gly-218, Gly-303 and 
Gly-447; and a microbodies C-terminal targeting signal at 
Ala-510. IFC1 was predicted to contain 37 acidic amino 
acid residues and 55 basic amino residues (pl = 8.6) that 
gave an average of 11.3 positive charges at neutral pH. 
Using the Kyte and Doolittle algorithm [35] with a window 
of l l amino acids, twelve potential membrane spanning 
segments were predicted at residues 27-42, 71-88, 93- 
115, 122-142, 156-178, 181-201, 272-292, 307-328, 
333-352, 362-384, 388-411, and 429-448. In the 3'-UTR 
a match of 5 out of 6 (5'-ATTAAA-3') to a polyadenyla- 
tion signal sequence (5'-AATAAA-3') at nucleotides 
2238-2243 was detected. 
Since plasmid pIFC1 was obtained through hybridiza- 
tion screening using as probe the mouse leukemia L1210 
reduced folate carrier RFCI cDNA insert of plasmid 
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IFCI(RFCI) 1 
IFCI(RFCI) 5 
IFCI(RFCI) 55 
RFC1 1 
IFCI(RFCl) 2005 
RFCl 1950 
IFCI(RFCI) 2055 
IFCI(RFCl) 2105 
IFCI(RFC1) 2155 
IFCI(RFC1) 2205 
IFCl(RFCl) 2255 
GGCA 
CGAGGCAATCTGCTGTGAGCTGAGACCCGGTCAAGCGCTGGACGGGTGGA 
GTGTCATCTTGC~CCGCCAGTTCCCATGAGGACCTGGGCAACATGGTGCC 
lllllllllllllllllllillllillli llllJiilllllllillill 
GTGTCATCTTGGCCCGCCAGTTCCCATGA-GACCTG~CATGGTGCC 
M V P 
... (homology cont inues)  ... 
GTGTCGGGCTCAACTATGCCCACCAGGCCATTCTGCCTTTTTTGCTCTGG 
Illllllillllilllllll 
GTGTCGGGCTCAACTATGCC 1969 
GAAGCTCTGGC42AAATCATGTCTC G C C TTAGGGCTAGTGAGGTAGCC A
GATGCCAGC AAGGTCCGCTGAGCC TGCAGGGTGCCAGTTGCCTGCCC TA 
GGC TC C TGGCTATGC TGC CATACATCC TTC CAC TATCGGAGGTGC TTGTT 
TAAATGGTTTTC TGATTTCTTTTTTAACTTGACATTAAAATGGAGAACTA 
CAAAAAAAAAAAAAAAAAAA 2274 
Fig. I. Comparison between IFCI(RFC1) and RFCI nucleotide sequences. The complete IFCI(RFCI) nucleotide sequence without the 3'-terminal 
poly(A) + has been submitted to GenBank (accession No. L36539). Shown here are IFCI(RFCI) sequences that represent additional information at the 5'- 
and 3'-termini in comparison to the published RFC1 sequence [20]. There is complete homology between IFCI(RFC1) nucleotides 55-2024 and RFCI 
nucleotides 1-1969, except for IFCI(RFCI) nucleotide 84, which represents an insertion of a G/C  base pair. Underlined nucleotides around the 
methionine initiation codon of the 1FCI(RFCI) open reading frame (ORF) denote matching nucleotides with the Kozak consensus equence 
(5'-GCCRCCATGG-3', R = purine). Underlined nucleotides near the 3'-end of the IFCI(RFC1) sequence denote matching nucleotides with the 
polyadenylation signal sequence (5'-AATAAA-3'). 
pRFC1 [20], we are interested in comparing the nucleotide 
sequence of the cDNA insert of plasmid pIFC1 to that of 
the published RFC1 sequence. The comparison shows that 
nucleotides 55-2024 of the cDNA insert in plasmid pIFC1 
are identical to the published 1969 nucleotides of RFCI, 
with the exception of nucleotide 84 of the cDNA insert in 
plasmid pIFCI which represents an G/C  insertion in the 
RFCI sequence. In other words, the cDNA insert in plas- 
mid pIFC1 contains 54 additional nucleotides at the 5'-end, 
an additional G /C  base pair at position 84 and 250 
additional nucleotides at the 3'-end, in comparison to the 
published RFCI sequence. It should be noted that the 
major ORF of the cDNA insert in plasmid pIFC1 is 
identical to that of the RFCI sequence. Thus the designa- 
tion IFCI(RFCI) will be used to refer to the cDNA insert 
of plasmid pIFC1 to denote the fact that the cDNA insert 
of plasmid pRFCI is contained within the cDNA insert of 
plasmid pIFC1 and the designation RFCI will be used to 
refer to the cDNA insert of plasmid pRFC1. 
3.2. Functional expression c~[" 1FCI(RFCI) in Xenopus 
oocytes 
In order to establish the functional identity of the cloned 
intestinal folate carrier IFCI(RFC1), we injected in vitro 
transcribed IFCI(RFC1) cRNA into oocytes. Control 
oocytes were injected with an equal amount of water. 
Oocytes injected with 10 ng of IFCI(RFC1) cRNA showed 
approximately a 11-fold increase in uptake of 3H-5-MTHF 
(0.25 /~M) after three days of incubation, compared to 
water-injected controls (73.0 _+ 5.7 vs. 6.7 _+ 0.6 
fmol/oocyte per h, respectively). By eight days after 
injection the expression of the folate transport system was 
approximately 16-fold greater than water-injected controls 
(110 _ 6.4 vs. 6.9 + 0.6 fmol/oocyte per h). In prelimi- 
nary studies, we found the uptake of 5-MTHF by 
1FCI(RFC1) cRNA-injected oocytes to be linear with time 
for 1 h of incubation (Y= 1.41 X+ 48.5; r = 0.99). Fur- 
thermore, the majority (94.4%) of the 3H radioactivity 
taken up by oocytes following incubation with 3H-MTHF 
(1.25 /~M) was found to be in the form of intact 5-MTHF. 
Furthermore, transport of 5-MTHF (0.25 /~M) by the 
expressed carrier was completely inhibited by the addition 
to the incubation medium of 1 mM DIDS, an inhibitor of 
anionic transport systems and of folate transport in native 
intestinal preparations [36,37] (4.9 _+ 0.1 vs. 110 + 7.2 
fmol/oocyte per h in cRNA-injected cells incubated with 
and without DIDS, respectively) (the K i for DIDS inhibi- 
tion was determined in a separate study and found to be 
4O0O 
300o 
C, 
2000 
100o 
e.~ 
2 4 6 8 10 1 2 
Folate (~M) 
Fig. 2. Uptake of folate by Xenopus oocytes injected with IFCI(RFCI) 
cRNA as a function of concentration, cRNA- and water-injected oocytes 
were incubated at room temperature for 1 h in normal Ringer buffer 
containing different concentrations of labeled and unlabeled 5-MTHF. 
Results are means_+ S.E. of 5-10 separate determinations. Kinetic param- 
eters of the uptake process were determined as described in Section 2. 
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Table 1 
Substrate specificity of IFCI(RFC1) expressed in Xenopus oocytes 
Condition Uptake P value ~ 
(fmol/oocyte 
per h) 
Control (water-injected) 5.0 + 0.8 (8) b 
Control (IFCI(RFC1) cRNA injected) 90 + 0.6 (8) 
5-MTHF (100 p,M) 1.1 _+ 0.4 (5) < 0.001 
Folinic acid (100/zM) 5.5 + 1.0 (5) < 0.001 
Folic acid (100 p,M) 35.8 + 3.2 (8) < 0.001 
Oocytes were incubated at room temperature for 1 h in Ringer buffer in 
the absence (control) or presence of the compound under study and 3H 
5-MTHF (0.25 ~zM). 
a p values were calculated using the Student's t-test; comparisons were 
made relative to simultaneously performed control experiments. 
b Number of oocytes. 
160/zM). In the same experiment, DIDS produced a slight 
inhibition of 5-MTHF uptake in water-injected controls 
(4.4___ 0.2 vs. 8.5 +_ 0.3 fmoi/oocyte per h in oocytes 
incubated with and without DIDS, respectively). In another 
study, we examined the uptake of 5-MTHF as a function 
of concentration (0.1 to 10 /xM) by the induced folate 
carrier following injection of IFCI(RFC1) cRNA (10 ng) 
into oocytes. Uptake by the induced carrier was deter- 
mined by subtracting the amount of 5-MTHF uptake at 
each concentration i water-injected oocytes from uptake 
by cRNA-injected cells. The results (Fig. 2) showed a 
clear saturation in 5-MTHF uptake with concentration. 
Kinetic parameters of the induced uptake carrier were then 
calculated using a computerized model of the Michaelis- 
Menten equation as described by Wilkinson [38], and 
found to be 1.99 + 0.32 /xM and 3782 _ 188 fmol/oocyte 
per h for the apparent K m and Vma x, respectively. We also 
examined the effect of unlabeled 5-MTHF and that of the 
structural analogs folinic acid and folic acid on the uptake 
of 3H-5-MTHF (0.25 /zM). As shown in Table 1, the 
uptake of 3H-5-MTHF by IFC1/RFC1 expressed in Xeno- 
pus oocytes was significantly inhibited by both reduced 
and oxidized folates. The inhibition constants (K i) were 
determined in a separate study and found to be 1.87 and 28 
tzM for folinic acid and folic acid, respectively. In a 
separate study, we examined the effect of buffer pH on the 
uptake of 5-MTHF (0.05 /xM) by the expressed folate 
carrier in cRNA-injected oocytes. The results showed a 
minor effect of pH on 5-MTHF uptake (22.8 + 0.96, 24.4 
_+ 2.8 and 22.8 _+ 0.9 fmol/oocyte per h at buffer pH of 
5.5, 6.5, and 8.0, respectively). 
3.3. Expression of mRNA species complementary to 
IFCI(RFCI) in different mouse tissues, in the small intes- 
tine of human and other animal species, and in different 
cultured intestinal epithelial cell lines 
In this study, we investigated the distribution of mRNA 
complementary to IFCI(RFC1) in different mouse tissues 
by Northern blot analysis. The results showed that at high 
stringency, predominant hybridization occurred between a
randomly labeled IFCI(RFC1) cDNA probe and a 2.3 kb 
mRNA species in mouse kidney, small intestine, large 
intestine, brain, heart and liver (Fig. 3). The degree of 
hybridization was highest in the kidney and lowest in the 
liver (data was normalized relative to the constitutively 
expressed gene cyclophilin). 
In another study, we examined by Northern blot analy- 
sis using a randomly labeled IFCI(RFC1) cDNA probe, 
the distribution of mRNA species complementary to 
IFCI(RFCI) in the small intestine of human and other 
animal species. Mouse small intestinal poly(A) ÷ RNA was 
also included as a positive control. As expected, the lane 
containing poly(A) + RNA of mouse intestine showed 
strong hybridization with a 2.3 kb mRNA species (Fig. 4). 
The lane containing poly(A) ÷ RNA of rat intestine showed 
hybridization of similar intensity but with a slightly smaller 
size mRNA species than 2.3 kb. On the other hand, the 
lane containing poly(A) ÷ RNA of the human small intes- 
tine showed hybridization of a lesser intensity with a 3.0 
o~ 
<-- IFC-1 
<--- cyc 
Fig. 3. Northern blot analysis for the presence of IFCI(RFC1) mRNA in various mouse tissues. Poly(A) ÷ RNA (5/zg), isolated from the indicated organs 
(see Section 2) was electrophoresed ona 1% agarose/20% formaldehyde RNA-denaturing gel. RNA was then blotted onto a nylon membrane by capillary 
transfer and UV-crosslinked. Hybridization and autoradiography were done as described in Section 2. 
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<_. 3.0 kb 
<" 2 .3kb  
Fig. 4. Northern blot analysis for the distribution of mRNA complemen- 
tary to 1FCI(RFC1) in the intestine of different animal species. Poly(A) + 
RNA (5 /xg) was isolated from the jejunum of different animal species 
and blotted and hybridized as described in Section 2 and Fig. 3. 
kb mRNA species, and the lane containing poly(A) + RNA 
of rabbit intestine showed an even less intense hybridiza- 
tion with 2.1 kb mRNA species. 
We also tested by Northern blot analysis whether an 
intestinal epithelial cell line in culture also possesses 
mRNA species that are complementary to IFCI(RFC1) 
cDNA.  For this we used the rat-derived non-transformed 
IEC-6 cells. Mouse intestinal poly(A) ÷ RNA was again 
included as a positive control. The results showed clear 
r.g3 i 
e 
Table 2 
Effect of incubation buffer pH, structural nalogs and DIDS on the uptake 
of 5-MTHF by the rat-derived intestinal epithelial cell line IEC-6 
Condition 5-MTHF uptake P value ~ 
(pmol/mg protein 
per 3 min) 
(A) Effect of pH 
pH 5.0 20.93 +0.51 (3) b 
pH 5.5 16.38 +0.24 (3) 
pH 6.0 13.30+0.43 ( ) 
pH 6.5 8.85+ 1.13 (3) 
pH 7.5 7.16± 1.11 (3) 
pH 8.0 5.09 ± 1.43 (3) 
(B) Effect of structural nalogs and DIDSc 
Control 12.78 +0.40 (6) 
Unlabeled 5-MTHF (25/zM) 3.43 +0.86 (6) < 0.01 
Methotrexate (25 ,aM) 3.03+0.52 (5) < 0.01 
Folic acid (25/zM) 3.11 +0.54 (5) < 0.01 
DIDS (1 mM) 4.51 + 0.66 (6) < 0.01 
Confluent IEC-6 cells were incubated in Krebs-Ringer buffer at 37°C. 
Incubation was performed for 3 min in the presence of 0.1 /xM 3H-5- 
MTHF. Data are means + S.E. Notice the pH-dependence in 5-MTHF 
uptake, and the significant inhibition in 3H-5-MTHF uptake by structural 
analogs and DIDS. 
a p values were calculated using the Student's t-test; comparisons were 
made relative to simultaneously performed control experiments. 
b Number of separate xperiments. 
c pH of the incubation buffer was 6.0. 
hybridization of  a randomly labeled IFCI(RFC1) cRNA 
with a 2.3 kb mRNA species in the mouse lane, and with a 
2.2 kb mRNA species in the IEC-6 lane (Fig. 5). Since no 
study exists to show whether IEC-6 cells have a folate 
uptake system, and whether such system is similar to that 
of the native small intestine, we performed a number of  
5 -MTHF uptake experiments to address these issues. The 
results showed that 5 -MTHF (0.1 /xM) uptake to be 
DIDS-sensit ive, pH-dependent and is inhibited by the 
structural analogs folic acid and methotrexate (Table 2). 
The inhibition constants for DIDS, folic acid, and 
methotrexate were determined in a separate study and 
found to be 97.9, 2.0, and 1.36 /xM, respectively. These 
results demonstrate the existence of a carrier-mediated 
system for 5 -MTHF uptake in these cells which is very 
similar to that of the native intestine [36,37,39]. 
<--- 2 .3kb  
Fig. 5. Northern blot analysis for the distribution of mRNA complemen- 
tary to IFCI(RFC1) in the intestinal cell line IEC-6. Poly(A) + RNA (5 
/xg) was isolated from mouse jejunum and from confluent cultures of 
IEC-6 cells, and blotted and hybridized as described in Section 2 and Fig. 
3. 
3.4. Expression of  mRNA complementary to IFCI(RFC1) 
in villus and crypt intestinal epithelial cells 
In this study we examined the relative abundance of 
mRNA complementary to IFCI(RFC1) in mature absorp- 
tive cells of  the villus tip and immature cells of  the crypt. 
Rat tissue was used as a source of  cells in these studies 
because the intestine of  this rodent species was found to 
contain a mRNA species that is complementary to 
IFCI(RFC1) (Fig. 4), and because of  practical reasons 
related to obtaining enough cells for isolation of  poly(A) + 
RNA and for confirmation of  cell origin. To quantitate the 
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Fig. 6. Northern blot analysis for the distribution of IFCI(RFC1) mRNA 
in crypt and villus cells. Poly(A) + RNA (5 p~g) was isolated from 
fractionated rat villus and crypt intestinal epithelial cells and blotted and 
hybridized as described in Section 2 and Fig. 3. 
level of expression of mRNA complementary to 
IFCI(RFCI), data was normalized relative to the constitu- 
tively expressed gene cyclophilin using a scanning den- 
sitometer (LKB; Bromma, Switzerland). The results (Fig. 
6) showed an approximately 10.5-fold higher expression of 
IFCI(RFC1) mRNA in epithelial cells of the villus tip than 
in crypt cells. 
4. Discussion 
To begin addressing the issues about the molecular 
identity and the cellular regulation of the intestinal folate 
transporters, we set out to isolate a cDNA clone of the 
mouse intestinal folate transporter, using a cDNA probe of 
the recently cloned reduced folate carrier (RFC1) of mouse 
leukemia L 1210 cells [20]. We constructed a cDNA library 
from doubly selected poly(A) ÷ RNA isolated from the 
proximal part of the mouse small intestine (i.e., the je- 
junum), which is the preferential site of intestinal absorp- 
tion of dietary folate. We identified a positive clone, 
IFCI(RFC1), which was virtually identical to RFC1 [20] 
except that IFCI(RFC1) contains, among other differ- 
ences, 55 additional nucleotides at the Y-end (Fig. 1). 
Because the 5'-region of the IFCI(RFC1) cDNA has not 
yet been completely mapped, further study will be needed 
to establish the regulatory significance of this sequence. 
The predicted IFCI(RFCI) polypeptide has a molecu- 
lar mass of 58 112 daltons, which is close to that of the 
intestinal folate transporter (56000 daltons) identified by 
Reizenhuer by affinity labeling [40]. The predicted 
IFCI(RFC1) polypeptide (pl  = 8.6) carries a net positive 
charge of 11.3 at physiological pH, which may be impor- 
tant in the interaction of the carrier protein with its nega- 
tively charged ligand (pK~ of folic acid are 3.5 and 4.8 for 
the a- and y-carboxyl groups, respectively). Previous stud- 
ies in our laboratory with group specific reagents have 
identified histidine residues at or near the substrate binding 
site of the intestinal folate carrier as functionally important 
[41]. It is interesting therefore to find out from the pre- 
dicted amino acid sequence that there are eight such 
histidine residues that are predicted to be either in the 
extra-membrane domain or in close proximity to the outer 
surfaces of the membrane. These residues might be the 
ones identified previously [41]. Studies of the effects of 
site-directed-mutagenesis on transport function will be re- 
quired to directly test this possibility. 
The functional involvement of IFCI(RFC1) in folate 
transport was confirmed by expression i  Xenopus oocytes 
and measuring the uptake of 5-MTHF. A significant in- 
crease in 5-MTHF uptake by oocytes micro-injected with 
IFCI(RFCI) cRNA was found in comparison to water-in- 
jected oocytes. This increase cannot be attributed to an 
increase in 5-MTHF metabolism in the cRNA-injected 
cells because 94.4% of the 3H radioactivity taken up by 
these cells following incubation with 3H-5-MTHF was 
found to be in the form of intact 5-MTHF. Furthermore, 
the anion transport inhibitor DIDS, which is membrane 
impermeable, completely inhibited the uptake of 5-MTHF 
by the induced carrier in cRNA-injected oocytes. The 
folate uptake system expressed in Xenopus oocytes fol- 
lowing micro-injection with IFCI(RFC1) cRNA was also 
found to be saturable as a function of 5-MTHF concentra- 
tion, with an apparent K m of 1.99 + 0.32 /zM and a Vm~ x
of 3782 + 188 fmol/oocyte per h. In addition, structural 
analogs of 5-MTHF significantly inhibited the uptake of 
3H-5-MTHF by the induced carrier. It is notable that the 
properties of the induced folate carrier in cRNA-injected 
oocytes with regard to DIDS sensitivity and apparent K m 
are very similar to those reported for folate transport in a 
variety of intestinal tissue preparations [36,37,39]. It is 
however different with regard to the pH profile. Uptake of 
folate in the native intestine is pH-dependent and increases 
with decreasing buffer pH. In contrast, the pH profile of 
the expressed folate carrier in Xenopus oocytes showed 
only minor response to buffer pH. Whether this effect is an 
indication for the existence of a tissue- (or cell-type)- 
specific post-translational modifications in the expressed 
folate carrier protein is not clear at present. Further studies 
are needed to address this issue. 
The distribution of mRNA complementary to 
IFCI(RFC1) cDNA in different mouse tissues was also 
investigated. Such mRNA was found not only in the small 
intestine but also in kidney, large intestine, brain and liver 
tissue. The finding of a mRNA species complementary to 
IFCI(RFC1) in the large intestine supports our recent 
demonstration f the existence of an efficient, specialized, 
DIDS-sensitive carrier-mediated system for folate transport 
in purified apical colonic membrane vesicles [42]. This 
system may be responsible for the absorption of folate 
produced by the normal microflora of the large intestine 
[43,44]. mRNA species complementary to IFCI(RFCI) 
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cDNA was also found in mature confluent monolayers of 
the rat-derived cultured intestinal epithelial cell line IEC-6. 
It is interesting that these homogenous cells were also 
found to possess a specialized carrier-mediated system for 
folate uptake which is similar to that of native rat intestine. 
These findings may suggest a role for IFCI(RFC1) in 
folate uptake (see below for further discussion) and also 
suggest he suitability of these cells as an in vitro model 
system to study cellular and molecular egulation of in- 
testinal folate transport process. 
mRNA species complementary to mouse intestinal 
IFCI(RFC1) were also observed by Northern blot analysis 
in the small intestine of human, rat and rabbit although the 
size of the message and the intensity of hybridization 
varied among those species. This suggests that despite 
some similarities, differences exist among the intestinal 
folate transporters of different animal species. Indeed, in a 
recent study, we screened a human small intestinal cDNA 
library (using a randomly labeled IFCI(RFCI) probe), 
identified and partially sequenced a clone that induces 
folate transport (by expression in Xenopus oocytes), and 
that shows 70% homology to IFCI(RFC1) (unpublished 
observation). Furthermore, IFCI(RFC1) also appears to be 
different from the recently cloned cDNAs of human pla- 
centa and human lymphoblastic ell line HSC93 which 
appear also to be involved in folate transport [45,46]. 
We also performed studies to identify relative distribu- 
tion of mRNA species complementary to IFCI(RFC1) in 
mature absorptive cells of the villus tip and the immature 
cells of the crypt. The results showed a 10-fotd higher 
abundance of mRNA complementary to IFCI(RFC1) in 
cells of the villus tip than in crypt cells. This finding 
further suggests a role for IFCI(RFC1) in the process of 
intestinal folate absorption. Further studies, however, are 
clearly required to test this possibility. 
In summary, the present study has identified a cDNA 
cloned from mouse small intestine that encodes a protein 
that is capable of transporting folate across cell membrane. 
This is the first demonstration of cloning of a folate 
transporter f om mammalian i testine. 
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